Literature DB >> 24808641

Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha.

Anshuman Sarangi1, P C Mohapatra1, R K Dalai2, Ashok Kumar Sarangi3.   

Abstract

We investigated the role of IL-4, IL-12 and TNF-alpha in clinically well-defined groups of Plasmodium falciparum and vivax (Pf & Pv) infected patients belonging to Group I (++), Group II (+++) and Group III (++++). On the basis of hematological parameters, hyperparasitaemia, and evidence of neurological involvement, three different levels of severity were selected attributing a score from Group I (++) to Group III (++++). In each group 16 patients each of P. falciparum and P. vivax malaria were studied. As a control group for cytokine determination 30 healthy volunteers were included in the study. Serum samples were analyzed for IL-12, IL-4 and TNF-alpha using (ELISA) obtained commercially (Ray Biotech). Hb levels of Pf and Pv patients were 8 ± 1.94, 7.6 ± 1.64 g/dl and 3.6 ± 1.23 and 10.1 ± 1.21, 9.4 ± 1.43 and 7.1 ± 0.98 g/dl. Serum iron levels of Pf and Pv patients were 85.86 ± 0.86, 81.10 ± 0.70 and 70.1 ± 0.73 and 99.47 ± 0.85, 96.67 ± 1.13 and 91.7 ± 2.65 mg/dl. TNF-alpha levels of Pf and Pv patients were 155 ± 23.66, 307.5 ± 111.87 and 955 ± 261.32 and 72 ± 9.93, 140.88 ± 23.11 and 469.37 ± 416.99 pg/ml. IL-12 levels of Pf and Pv patients were 117.5 ± 8.16, 160.63 ± 20.81 and 293.13 ± 94.64 and 75.7 ± 9.25, 112.9 ± 12.05 and 200 ± 53.78 pg/ml. IL-4 levels of Pf and Pv patients were 3.7 ± 0.11, 3.2 ± 0.13 and 2.3 ± 0.63 and 5.33 ± 1.08, 4.8 ± 0.16 and 3.9 ± 0.48 pg/ml. In the control group the values of TNF-alpha, IL-12 and IL-4 were 42.9 ± 13.5, 49.8 ± 11.59 and 6.06 ± 1.32 pg/ml respectively. Cytokines and poor oxygen delivery should not be viewed as alternative theories of malarial disease pathophysiology instead poor oxygen delivery is one of the consequences of excessive release of inflammatory cytokines which is further augmented by the present work.

Entities:  

Keywords:  Clinical severity; Cytokines; IL-12; IL-4; Malaria; TNF-alpha

Year:  2013        PMID: 24808641      PMCID: PMC4000367          DOI: 10.1007/s12639-013-0237-1

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  16 in total

Review 1.  Interleukin-12 and malaria.

Authors:  J M Crutcher; M M Stevenson; M Sedegah; S L Hoffman
Journal:  Res Immunol       Date:  1995 Sep-Oct

2.  Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum.

Authors:  L M Kumaratilake; A Ferrante; C M Rzepczyk
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 3.  The immunology of malaria infection.

Authors:  M Plebanski; A V Hill
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

Review 4.  Is T-cell priming required for initiation of pathology in malaria infections?

Authors:  E M Riley
Journal:  Immunol Today       Date:  1999-05

5.  The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria.

Authors:  N P Day; T T Hien; T Schollaardt; P P Loc; L V Chuong; T T Chau; N T Mai; N H Phu; D X Sinh; N J White; M Ho
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

6.  Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria.

Authors:  S Winkler; M Willheim; K Baier; D Schmid; A Aichelburg; W Graninger; P G Kremsner
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

8.  Plasma levels of interleukin-18 and interleukin-12 in Plasmodium falciparum malaria.

Authors:  Lucia Malaguarnera; Salvatore Pignatelli; Maria Musumeci; Jacques Simporè; Salvatore Musumeci
Journal:  Parasite Immunol       Date:  2002 Sep-Oct       Impact factor: 2.280

Review 9.  The immune response to Plasmodium falciparum malaria.

Authors:  Lucia Malaguarnera; Salvatore Musumeci
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

10.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  7 in total

1.  Enteroparasite and vivax malaria co-infection on the Brazil-French Guiana border: Epidemiological, haematological and immunological aspects.

Authors:  Rubens Alex de Oliveira Menezes; Margarete do Socorro Mendonça Gomes; Anapaula Martins Mendes; Álvaro Augusto Ribeiro D' Almeida Couto; Mathieu Nacher; Tamirys Simão Pimenta; Aline Collares Pinheiro de Sousa; Andrea Regina de Souza Baptista; Maria Izabel de Jesus; Martin Johannes Enk; Maristela Gomes Cunha; Ricardo Luiz Dantas Machado
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

2.  Synergistic effect of IL-12 and IL-18 induces TIM3 regulation of γδ T cell function and decreases the risk of clinical malaria in children living in Papua New Guinea.

Authors:  Louis Schofield; Lisa J Ioannidis; Stephan Karl; Leanne J Robinson; Qiao Y Tan; Daniel P Poole; Inoni Betuela; Danika L Hill; Peter M Siba; Diana S Hansen; Ivo Mueller; Emily M Eriksson
Journal:  BMC Med       Date:  2017-06-15       Impact factor: 8.775

3.  Cytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes.

Authors:  Carlota Dobaño; Azucena Bardají; Myriam Arévalo-Herrera; Flor E Martínez-Espinosa; Camila Bôtto-Menezes; Norma Padilla; Michela Menegon; Swati Kochar; Sanjay Kumar Kochar; Holger Unger; Maria Ome-Kaius; Anna Rosanas-Urgell; Adriana Malheiros; Maria Eugenia Castellanos; Dhiraj Hans; Meghna Desai; Aina Casellas; Chetan E Chitnis; Carlo Severini; Ivo Mueller; Stephen Rogerson; Clara Menéndez; Pilar Requena
Journal:  PLoS Negl Trop Dis       Date:  2020-05-04

4.  A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria.

Authors:  Manisha Pritam; Garima Singh; Suchit Swaroop; Akhilesh Kumar Singh; Brijesh Pandey; Satarudra Prakash Singh
Journal:  Int J Biol Macromol       Date:  2020-04-29       Impact factor: 6.953

5.  Low Interleukin-12 Levels concerning Severe Malaria: A Systematic Review and Meta-Analysis.

Authors:  Polrat Wilairatana; Pattamaporn Kwankaew; Kwuntida Uthaisar Kotepui; Manas Kotepui
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

6.  IL-4, IL-10, CCL2 and TGF-β as potential biomarkers for severity in Plasmodium vivax malaria.

Authors:  Catalina Tovar Acero; Javier Ramírez-Montoya; María Camila Velasco; Paula A Avilés-Vergara; Dina Ricardo-Caldera; Miquel Duran-Frigola; Gustavo Quintero; Myriam Elena Cantero; Juan Rivera-Correa; Ana Rodriguez; María Fernanda Yasnot-Acosta
Journal:  PLoS Negl Trop Dis       Date:  2022-09-30

7.  Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life.

Authors:  Hamtandi Magloire Natama; Gemma Moncunill; Eduard Rovira-Vallbona; Héctor Sanz; Hermann Sorgho; Ruth Aguilar; Maminata Coulibaly-Traoré; M Athanase Somé; Susana Scott; Innocent Valéa; Petra F Mens; Henk D F H Schallig; Luc Kestens; Halidou Tinto; Carlota Dobaño; Anna Rosanas-Urgell
Journal:  BMC Med       Date:  2018-11-02       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.